Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
What makes HealthEquitys GLP-1 telehealth platform unique isnt just access to care its how it integrates treatment, prescription management, and payment
Nothing herein is medical, veterinary or dosing advice, and no statement should be interpreted as a recommendation for use in humans or animals
If all Phase 3 trials succeed and the NDA is submitted in late 2026, FDA approval could come in late 2027 to early 2028
"Ro not only expands access to effective GLP-1 medications, but also gives each patient regular consultations with their provider, ongoing coaching, and convenient follow-up to maintain their progress
US$ 27.61
US$ 27.16
US$ 26.20
US$ 24.68
US$ 24.03
US$ 21.54
